Parameter Set Benzodiazepines 2 - LC-MS/MS
Encompasses 10 analytes
3PLUS1® Multilevel Calibrator Set available
Part of the MassTox® TDM Series A
CE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
Alprazolam
Bromazepam
Clonazepam
Flunitrazepam
Flurazepam
Desalkylflurazepam
Lorazepam
Lormetazepam
Nitrazepam
Triazolam
Clinical relevance
Benzodiazepines (BZD) are a group of psychoactive drugs with similar structures that are classified as sedatives. By virtue of their high lipophilicity they penetrate the blood-brain barrier easily and, after being resorbed, quickly reach the central nervous system, where they enhance the impact of the inhibiting neurotransmitter GABA. Besides anxiolytic and sedative effects, BZD also have anti-aggressive, hypnotic, muscle relaxant and anticonvulsive properties. The predominance of the individual effects varies with the special structures of the benzodiazepines and the administered dose. BZD in blood are present mostly bound nonspecifically to plasma proteins. They are metabolised mainly by the liver. The resulting metabolites are mostly pharmacologically active themselves, and in some cases they represent the actual active substance, e.g. nordiazem being metabolised from diazepam or clorazepate. The plasma elimination times are highly variable: from a few hours (midazolam) to several days (clobazam). The metabolites frequently have longer half-lives than the parent substance, so an enrichment of therapeutically effective substances in the blood can occur.
Product advantages
With the Parameter Set Benzodiazepines 2 in serum/plasma, 10 different drugs can be measured quickly and efficiently using LC-MS/MS. By carefully optimising all of the kit components and the chromatographic separation, matrix effects (“ion suppression”) have been minimised and the robustness of the method has been enhanced. Sample preparation is based on protein precipitation. The use of stable isotopically labelled (deuterated) and co-eluting internal standards as well as 3PLUS1® multilevel calibrators ensures high precision and reproducible and reliable quantification of the analytes. The method is comprehensively validated.
The Parameter Set is a part of the Series A modular system, which enables the analysis of all parameters without switching column or changing the mobile phases, thereby minimising required workload in the laboratory. The Basic Kit A contains all components required for sample preparation and all necessary mobile phases. The MasterColumn® A is the analytical column used for the determination of all Series A analytes. Our portfolio contains further MassTox® Parameter Sets.
For the analysis you require the MassTox® TDM Basic Kit A, the specific MassTox® TDM Parameter Set and the analytical column MassTox® TDM MasterColumn® A.
Method of Analysis | LC-MS/MS |
---|---|
Please note | The freely available information on this website, in particular on the sample preparation, are not sufficient to work with our products. Please read instructions and warning notices on products and/or instruction manuals. |
Lower Limit of Quantitation | 1 – 10 µg/l |
Upper Limit of Quantification | up to 50 – 750 μg/l |
Intraassay | CV = 2 – 9 % |
Interassay | CV = 6 – 14 % |
Recovery | 90 – 109 % |
Specimen | Serum/Plasma |
Sample Preparation |
|
Run Time | 2.8 min |
Injection Volume | 0.2 – 50 µl |
Gradient | 0.00 - 0.30 min 20 % Mobile Phase 2 |
Ionisation | ESI positive |
MS/MS Mode | MRM |
Additional Info | We recommend to set the scan time to a value that allows to achieve a minimum of 10 data points over the whole peak width. |
Parameters | Alprazolam, Bromazepam, Clonazepam, Desalkylflurazepam, Flunitrazepam, Flurazepam, Lorazepam, Lormetazepam, Nitrazepam, Triazolam |
-
Internal Standard Mix BenzodiazepinesOrder no.: 92346Component of the Parameter Sets Benzodiazepines 1 and 2, available separately
-
3PLUS1® Multilevel Plasma Calibrator Set Benzodiazepines 2Order no.: 92031MassTox® TDM Series A Benzodiazepines 2 in Serum/Plasma – LC-MS/MS
-
MassTox® TDM MasterColumn® AOrder no.: 92110
Analytical column for MassTox® TDM Series A - LC-MS/MS
-
Tuning Mix Benzodiazepines 2Order no.: 92021Tuning Mix for the Parameter Set Benzodiazepines 2 - LC-MS/MS
-
Basic Kit A for 200 Tests - LC-MS/MSOrder no.: 92111/200
Part of the MassTox® TDM Series A
Modular system for therapeutic drug monitoring
Provides all components required for sample prep and all mobile phasesCE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
-
Basic Kit A for 1000 Tests - LC-MS/MSOrder no.: 92111/1000
Part of the MassTox® TDM Series A
Modular system for therapeutic drug monitoring
Provides all components required for sample prep and all mobile phasesCE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
-
3PLUS1® Multilevel Plasma Calibrator Set Benzodiazepines 2Order no.: 92031MassTox® TDM Series A Benzodiazepines 2 in Serum/Plasma – LC-MS/MS
Alprazolam
Bromazepam
Clonazepam
Flunitrazepam
Flurazepam
Desalkylflurazepam
Lorazepam
Lormetazepam
Nitrazepam
Triazolam
Clinical relevance
Benzodiazepines (BZD) are a group of psychoactive drugs with similar structures that are classified as sedatives. By virtue of their high lipophilicity they penetrate the blood-brain barrier easily and, after being resorbed, quickly reach the central nervous system, where they enhance the impact of the inhibiting neurotransmitter GABA. Besides anxiolytic and sedative effects, BZD also have anti-aggressive, hypnotic, muscle relaxant and anticonvulsive properties. The predominance of the individual effects varies with the special structures of the benzodiazepines and the administered dose. BZD in blood are present mostly bound nonspecifically to plasma proteins. They are metabolised mainly by the liver. The resulting metabolites are mostly pharmacologically active themselves, and in some cases they represent the actual active substance, e.g. nordiazem being metabolised from diazepam or clorazepate. The plasma elimination times are highly variable: from a few hours (midazolam) to several days (clobazam). The metabolites frequently have longer half-lives than the parent substance, so an enrichment of therapeutically effective substances in the blood can occur.
Product advantages
With the Parameter Set Benzodiazepines 2 in serum/plasma, 10 different drugs can be measured quickly and efficiently using LC-MS/MS. By carefully optimising all of the kit components and the chromatographic separation, matrix effects (“ion suppression”) have been minimised and the robustness of the method has been enhanced. Sample preparation is based on protein precipitation. The use of stable isotopically labelled (deuterated) and co-eluting internal standards as well as 3PLUS1® multilevel calibrators ensures high precision and reproducible and reliable quantification of the analytes. The method is comprehensively validated.
The Parameter Set is a part of the Series A modular system, which enables the analysis of all parameters without switching column or changing the mobile phases, thereby minimising required workload in the laboratory. The Basic Kit A contains all components required for sample preparation and all necessary mobile phases. The MasterColumn® A is the analytical column used for the determination of all Series A analytes. Our portfolio contains further MassTox® Parameter Sets.
For the analysis you require the MassTox® TDM Basic Kit A, the specific MassTox® TDM Parameter Set and the analytical column MassTox® TDM MasterColumn® A.
Method of Analysis | LC-MS/MS |
---|---|
Please note | The freely available information on this website, in particular on the sample preparation, are not sufficient to work with our products. Please read instructions and warning notices on products and/or instruction manuals. |
Lower Limit of Quantitation | 1 – 10 µg/l |
Upper Limit of Quantification | up to 50 – 750 μg/l |
Intraassay | CV = 2 – 9 % |
Interassay | CV = 6 – 14 % |
Recovery | 90 – 109 % |
Specimen | Serum/Plasma |
Sample Preparation |
|
Run Time | 2.8 min |
Injection Volume | 0.2 – 50 µl |
Gradient | 0.00 - 0.30 min 20 % Mobile Phase 2 |
Ionisation | ESI positive |
MS/MS Mode | MRM |
Additional Info | We recommend to set the scan time to a value that allows to achieve a minimum of 10 data points over the whole peak width. |
Parameters | Alprazolam, Bromazepam, Clonazepam, Desalkylflurazepam, Flunitrazepam, Flurazepam, Lorazepam, Lormetazepam, Nitrazepam, Triazolam |
-
Internal Standard Mix BenzodiazepinesOrder no.: 92346Component of the Parameter Sets Benzodiazepines 1 and 2, available separately
-
3PLUS1® Multilevel Plasma Calibrator Set Benzodiazepines 2Order no.: 92031MassTox® TDM Series A Benzodiazepines 2 in Serum/Plasma – LC-MS/MS
-
MassTox® TDM MasterColumn® AOrder no.: 92110
Analytical column for MassTox® TDM Series A - LC-MS/MS
-
Tuning Mix Benzodiazepines 2Order no.: 92021Tuning Mix for the Parameter Set Benzodiazepines 2 - LC-MS/MS
-
Basic Kit A for 200 Tests - LC-MS/MSOrder no.: 92111/200
Part of the MassTox® TDM Series A
Modular system for therapeutic drug monitoring
Provides all components required for sample prep and all mobile phasesCE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
-
Basic Kit A for 1000 Tests - LC-MS/MSOrder no.: 92111/1000
Part of the MassTox® TDM Series A
Modular system for therapeutic drug monitoring
Provides all components required for sample prep and all mobile phasesCE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
-
3PLUS1® Multilevel Plasma Calibrator Set Benzodiazepines 2Order no.: 92031MassTox® TDM Series A Benzodiazepines 2 in Serum/Plasma – LC-MS/MS